Relative safety of first-time volunteer and replacement donors in West Africa.
Identifieur interne : 000539 ( PubMed/Curation ); précédent : 000538; suivant : 000540Relative safety of first-time volunteer and replacement donors in West Africa.
Auteurs : Jean-Pierre Allain [Royaume-Uni] ; Francis Sarkodie ; Kwame Asenso-Mensah ; Shirley Owusu-OforiSource :
- Transfusion [ 1537-2995 ] ; 2010.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Anticorps anti-VIH (sang), Anticorps de l'hépatite C (sang), Antigènes de surface du virus de l'hépatite B (sang), Bénévoles, Donneurs de sang (), Donneurs de sang (psychologie), Dépistage systématique, Facteurs de l'âge, Femelle, Ghana (épidémiologie), Humains, Hépatite B (), Hépatite B (sang), Hépatite B (transmission), Hépatite B (épidémiologie), Hépatite C (), Hépatite C (sang), Hépatite C (transmission), Hépatite C (épidémiologie), Infections à VIH (), Infections à VIH (sang), Infections à VIH (transmission), Infections à VIH (épidémiologie), Jeune adulte, Motivation, Mâle, Sécurité, Sélection de donneurs (), Sélection de donneurs (normes), Sélection de donneurs (économie), Séroprévalence du VIH, Études séroépidémiologiques.
- MESH :
- normes : Sélection de donneurs.
- psychologie : Donneurs de sang.
- sang : Anticorps anti-VIH, Anticorps de l'hépatite C, Antigènes de surface du virus de l'hépatite B, Hépatite B, Hépatite C, Infections à VIH.
- économie : Hépatite B, Hépatite C, Infections à VIH, Sélection de donneurs.
- épidémiologie : Ghana, Hépatite B, Hépatite C, Infections à VIH.
- Adolescent, Adulte, Adulte d'âge moyen, Bénévoles, Donneurs de sang, Dépistage systématique, Facteurs de l'âge, Femelle, Humains, Hépatite B, Hépatite C, Infections à VIH, Jeune adulte, Motivation, Mâle, Sécurité, Sélection de donneurs, Séroprévalence du VIH, Études séroépidémiologiques.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- Adolescent, Adult, Age Factors, Blood Donors (psychology), Blood Donors (statistics & numerical data), Donor Selection (economics), Donor Selection (standards), Donor Selection (statistics & numerical data), Female, Ghana (epidemiology), HIV Antibodies (blood), HIV Infections (blood), HIV Infections (epidemiology), HIV Infections (prevention & control), HIV Infections (transmission), HIV Seroprevalence, Hepatitis B (blood), Hepatitis B (epidemiology), Hepatitis B (prevention & control), Hepatitis B (transmission), Hepatitis B Surface Antigens (blood), Hepatitis C (blood), Hepatitis C (epidemiology), Hepatitis C (prevention & control), Hepatitis C (transmission), Hepatitis C Antibodies (blood), Humans, Male, Mass Screening, Middle Aged, Motivation, Safety, Seroepidemiologic Studies, Volunteers, Young Adult.
- MESH :
- chemical , blood : HIV Antibodies, Hepatitis B Surface Antigens, Hepatitis C Antibodies.
- geographic , epidemiology : Ghana.
- blood : HIV Infections, Hepatitis B, Hepatitis C.
- economics : Donor Selection.
- epidemiology : HIV Infections, Hepatitis B, Hepatitis C.
- prevention & control : HIV Infections, Hepatitis B, Hepatitis C.
- psychology : Blood Donors.
- standards : Donor Selection.
- statistics & numerical data : Blood Donors, Donor Selection.
- transmission : HIV Infections, Hepatitis B, Hepatitis C.
- Adolescent, Adult, Age Factors, Female, HIV Seroprevalence, Humans, Male, Mass Screening, Middle Aged, Motivation, Safety, Seroepidemiologic Studies, Volunteers, Young Adult.
Abstract
A significantly higher level of safety between nonremunerated volunteer and replacement donor blood is assumed. This is supported by global data without stratifying between genuine replacement and paid donors, for first-time or repeat volunteer, or according to age.
DOI: 10.1111/j.1537-2995.2009.02444.x
PubMed: 19843284
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000539
Links to Exploration step
pubmed:19843284Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Relative safety of first-time volunteer and replacement donors in West Africa.</title>
<author><name sortKey="Allain, Jean Pierre" sort="Allain, Jean Pierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge, UK. jpa1000@cam.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name>
</author>
<author><name sortKey="Asenso Mensah, Kwame" sort="Asenso Mensah, Kwame" uniqKey="Asenso Mensah K" first="Kwame" last="Asenso-Mensah">Kwame Asenso-Mensah</name>
</author>
<author><name sortKey="Owusu Ofori, Shirley" sort="Owusu Ofori, Shirley" uniqKey="Owusu Ofori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:19843284</idno>
<idno type="pmid">19843284</idno>
<idno type="doi">10.1111/j.1537-2995.2009.02444.x</idno>
<idno type="wicri:Area/PubMed/Corpus">000539</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000539</idno>
<idno type="wicri:Area/PubMed/Curation">000539</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000539</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Relative safety of first-time volunteer and replacement donors in West Africa.</title>
<author><name sortKey="Allain, Jean Pierre" sort="Allain, Jean Pierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge, UK. jpa1000@cam.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name>
</author>
<author><name sortKey="Asenso Mensah, Kwame" sort="Asenso Mensah, Kwame" uniqKey="Asenso Mensah K" first="Kwame" last="Asenso-Mensah">Kwame Asenso-Mensah</name>
</author>
<author><name sortKey="Owusu Ofori, Shirley" sort="Owusu Ofori, Shirley" uniqKey="Owusu Ofori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name>
</author>
</analytic>
<series><title level="j">Transfusion</title>
<idno type="eISSN">1537-2995</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Blood Donors (psychology)</term>
<term>Blood Donors (statistics & numerical data)</term>
<term>Donor Selection (economics)</term>
<term>Donor Selection (standards)</term>
<term>Donor Selection (statistics & numerical data)</term>
<term>Female</term>
<term>Ghana (epidemiology)</term>
<term>HIV Antibodies (blood)</term>
<term>HIV Infections (blood)</term>
<term>HIV Infections (epidemiology)</term>
<term>HIV Infections (prevention & control)</term>
<term>HIV Infections (transmission)</term>
<term>HIV Seroprevalence</term>
<term>Hepatitis B (blood)</term>
<term>Hepatitis B (epidemiology)</term>
<term>Hepatitis B (prevention & control)</term>
<term>Hepatitis B (transmission)</term>
<term>Hepatitis B Surface Antigens (blood)</term>
<term>Hepatitis C (blood)</term>
<term>Hepatitis C (epidemiology)</term>
<term>Hepatitis C (prevention & control)</term>
<term>Hepatitis C (transmission)</term>
<term>Hepatitis C Antibodies (blood)</term>
<term>Humans</term>
<term>Male</term>
<term>Mass Screening</term>
<term>Middle Aged</term>
<term>Motivation</term>
<term>Safety</term>
<term>Seroepidemiologic Studies</term>
<term>Volunteers</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Anticorps anti-VIH (sang)</term>
<term>Anticorps de l'hépatite C (sang)</term>
<term>Antigènes de surface du virus de l'hépatite B (sang)</term>
<term>Bénévoles</term>
<term>Donneurs de sang ()</term>
<term>Donneurs de sang (psychologie)</term>
<term>Dépistage systématique</term>
<term>Facteurs de l'âge</term>
<term>Femelle</term>
<term>Ghana (épidémiologie)</term>
<term>Humains</term>
<term>Hépatite B ()</term>
<term>Hépatite B (sang)</term>
<term>Hépatite B (transmission)</term>
<term>Hépatite B (épidémiologie)</term>
<term>Hépatite C ()</term>
<term>Hépatite C (sang)</term>
<term>Hépatite C (transmission)</term>
<term>Hépatite C (épidémiologie)</term>
<term>Infections à VIH ()</term>
<term>Infections à VIH (sang)</term>
<term>Infections à VIH (transmission)</term>
<term>Infections à VIH (épidémiologie)</term>
<term>Jeune adulte</term>
<term>Motivation</term>
<term>Mâle</term>
<term>Sécurité</term>
<term>Sélection de donneurs ()</term>
<term>Sélection de donneurs (normes)</term>
<term>Sélection de donneurs (économie)</term>
<term>Séroprévalence du VIH</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>HIV Antibodies</term>
<term>Hepatitis B Surface Antigens</term>
<term>Hepatitis C Antibodies</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>HIV Infections</term>
<term>Hepatitis B</term>
<term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Donor Selection</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term>
<term>Hepatitis B</term>
<term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Sélection de donneurs</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term>
<term>Hepatitis B</term>
<term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Donneurs de sang</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Blood Donors</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps anti-VIH</term>
<term>Anticorps de l'hépatite C</term>
<term>Antigènes de surface du virus de l'hépatite B</term>
<term>Hépatite B</term>
<term>Hépatite C</term>
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Donor Selection</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Blood Donors</term>
<term>Donor Selection</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term>
<term>Hepatitis B</term>
<term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Hépatite B</term>
<term>Hépatite C</term>
<term>Infections à VIH</term>
<term>Sélection de donneurs</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term>
<term>Hépatite B</term>
<term>Hépatite C</term>
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Female</term>
<term>HIV Seroprevalence</term>
<term>Humans</term>
<term>Male</term>
<term>Mass Screening</term>
<term>Middle Aged</term>
<term>Motivation</term>
<term>Safety</term>
<term>Seroepidemiologic Studies</term>
<term>Volunteers</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Bénévoles</term>
<term>Donneurs de sang</term>
<term>Dépistage systématique</term>
<term>Facteurs de l'âge</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hépatite B</term>
<term>Hépatite C</term>
<term>Infections à VIH</term>
<term>Jeune adulte</term>
<term>Motivation</term>
<term>Mâle</term>
<term>Sécurité</term>
<term>Sélection de donneurs</term>
<term>Séroprévalence du VIH</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A significantly higher level of safety between nonremunerated volunteer and replacement donor blood is assumed. This is supported by global data without stratifying between genuine replacement and paid donors, for first-time or repeat volunteer, or according to age.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19843284</PMID>
<DateCreated><Year>2010</Year>
<Month>03</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>03</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-2995</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>50</Volume>
<Issue>2</Issue>
<PubDate><Year>2010</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Transfusion</Title>
<ISOAbbreviation>Transfusion</ISOAbbreviation>
</Journal>
<ArticleTitle>Relative safety of first-time volunteer and replacement donors in West Africa.</ArticleTitle>
<Pagination><MedlinePgn>340-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1537-2995.2009.02444.x</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A significantly higher level of safety between nonremunerated volunteer and replacement donor blood is assumed. This is supported by global data without stratifying between genuine replacement and paid donors, for first-time or repeat volunteer, or according to age.</AbstractText>
<AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">In 2008, first-time volunteer and replacement donors were identified, and confirmed human immunodeficiency virus antibody (anti-HIV), hepatitis B surface antigen (HBsAg), and hepatitis C virus antibody (anti-HCV)-positive screening results were collated. Data were analyzed according to age and sex between the two types of donors.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In 6640 first-time volunteer and 4360 replacement donors, the prevalence of anti-HIV and HBsAg (1.03 and 13.8% vs. 1.1 and 14.9%, respectively) was not significantly different. Anti-HIV prevalence was higher in replacement donors less than age 20 than in first-time volunteers; the difference was not significant. HBsAg and anti-HIV confirmed-positive prevalence was significantly higher in first-time volunteer donors over age 20.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In Kumasi, Ghana, viral safety of replacement and first-time volunteer donors was similar, constituting a single population of donors. Safety increment is provided by repeat donation applicable to either group, through different approaches. A blood unit from replacement donor costs half or less than that from a volunteer donor; similar studies conducted elsewhere in sub-Saharan Africa may lead to changes in current strategies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allain</LastName>
<ForeName>Jean-Pierre</ForeName>
<Initials>JP</Initials>
<AffiliationInfo><Affiliation>Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge, UK. jpa1000@cam.ac.uk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sarkodie</LastName>
<ForeName>Francis</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Asenso-Mensah</LastName>
<ForeName>Kwame</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Owusu-Ofori</LastName>
<ForeName>Shirley</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2009</Year>
<Month>10</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Transfusion</MedlineTA>
<NlmUniqueID>0417360</NlmUniqueID>
<ISSNLinking>0041-1132</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006514">Hepatitis B Surface Antigens</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018937">Hepatitis C Antibodies</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Transfusion. 2010 Aug;50(8):1850-1; author reply 1851-2</RefSource>
<PMID Version="1">20883254</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>Transfusion. 2010 Aug;50(8):1849-50; author reply 1851-2</RefSource>
<PMID Version="1">20883253</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001782" MajorTopicYN="N">Blood Donors</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D046148" MajorTopicYN="N">Donor Selection</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015528" MajorTopicYN="N">HIV Seroprevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006514" MajorTopicYN="N">Hepatitis B Surface Antigens</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006526" MajorTopicYN="N">Hepatitis C</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018937" MajorTopicYN="N">Hepatitis C Antibodies</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009042" MajorTopicYN="N">Motivation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012449" MajorTopicYN="N">Safety</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014838" MajorTopicYN="Y">Volunteers</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>3</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19843284</ArticleId>
<ArticleId IdType="pii">TRF2444</ArticleId>
<ArticleId IdType="doi">10.1111/j.1537-2995.2009.02444.x</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000539 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000539 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaGhanaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:19843284 |texte= Relative safety of first-time volunteer and replacement donors in West Africa. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19843284" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SidaGhanaV1
This area was generated with Dilib version V0.6.31. |